The Future of AI in Medical Devices: FDA Guidelines & the Value of Imaging Data Artificial Intelligence (AI) and Machine Learning (ML) are transforming medical devices — enabling faster, more accurate diagnostics, smarter treatment plans, and adaptive learning from real-world use. But as AI evolves, so does the regulatory landscape. In our latest blog, the Segmed Team explores: 🔹 How the FDA’s evolving guidance supports AI/ML-based medical devices 🔹 Key challenges for AI developers, from dataset bias to privacy hurdles 🔹 The critical role of real-world imaging data (RWiD) in creating regulatory-grade, generalizable AI models With access to 100M de-identified, annotated imaging studies from 2,000+ healthcare locations worldwide, Segmed empowers AI and MedTech developers to build safer, effective, and FDA-ready medical devices. 📖 Read the full blog: https://www.segmed.ai/resources/blog/future-of-ai-powered-medical-devices-fda-insights











